Breast biopsy device market to be worth $2,037.69 million by 2030

The “Breast Biopsy Devices Market by Product (Biopsy Needles, Biopsy Tables, Guidance Systems), Test (Breast Needle Biopsy, Surgical Biopsy), Guidance, End Use – Global Forecast 2024-2030” report has been added to 360iResearch.com’s offering.

Request a free sample report @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Breast biopsy devices, including needle biopsy systems, core needle biopsy systems, fine needle aspiration systems, and vacuum-assisted biopsy systems, are essential diagnostic tools for detecting abnormalities of breast tissue such as lumps or calcifications to determine whether they are benign or malignant. The rising incidence of breast cancer and increased public awareness emphasize the need for accurate and early diagnosis, which is driving the demand for these devices in clinical and hospital settings. Support for cancer research, advancement in minimally invasive techniques, and increased public awareness are further boosting the market growth. Hospitals, diagnostic centers, and ambulatory surgical centers (ASCs) are significant end-users. Market growth opportunities include integration of artificial intelligence in biopsy procedures, expansion into emerging markets with improved healthcare infrastructure, and development of customizable biopsy devices for specific demographic groups. Industry recommendations emphasize increased investment in research and development (R&D) for user-friendly devices, strengthening the distribution network to reach a wider customer base, and collaboration with research institutions and healthcare providers to achieve technological advancements. However, challenges such as high procedure costs, technical complexity requiring specialized training, and stringent regulatory standards may hinder market growth. Ongoing innovation and research are focused on non-invasive techniques, development of portable and easy-to-use devices, and use of biocompatible materials to enhance device safety and patient comfort. Rapid technological advancements in the market and emphasis on minimally invasive procedures suggest a dynamic and competitive landscape that requires companies to keep up with emerging trends and customer preferences to maintain a competitive edge. Overall, the breast biopsy device market exhibits significant growth potential driven by rising cancer awareness, technological innovations, and supportive government initiatives, although addressing inherent challenges remains crucial to achieve sustainable growth and market leadership.

Ask before buying @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

Market segmentation and reach:

This research report categorizes the Breast Biopsy Devices market to forecast revenue and analyze trends in each of the following submarkets:

On a product basis, the market for biopsy needles, biopsy tables, guidance systems and localization wires is examined.

Based on the test, the market is being studied in the field of breast needle biopsy and surgical biopsy. Breast needle biopsy is further studied in the field of core needle aspiration, fine needle aspiration and vacuum-assisted core biopsy. Surgical biopsy is further studied in the field of breast excision biopsy and breast incisional biopsy.

Based on the guidelines, the market for MRI-guided, mammography-guided and ultrasound-guided stereotactic systems is examined.

Based on end use, the market is examined in diagnostic centers, hospitals and clinics.

On the basis of region, the market is studied across Americas, Asia Pacific, and Europe, Middle East, and Africa. Americas is further studied across Argentina, Brazil, Canada, Mexico, and the United States. United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. Asia Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East, and Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, UAE, and the United Kingdom.

Key company profiles:

The report delves into the recent significant developments in the Breast Biopsy Devices market, highlighting the leading vendors and their innovative profiles. These include Advin Health Care, Argon Medical Devices, Inc., Becton, Dickinson and Company, Cook Group Incorporated, Danaher Corporation, FUJIFILM Corporation, GE HealthCare Technologies Inc., Halma plc, Hologic, Inc, INRAD Inc., Medline Industries, LP, Medtronic PLC, Merit Medical Systems, Inc., Ningbo Xinwell Medical Technology Co., LTD., PAJUNK GmbH, Planmeca Oy, Point Blank Medical, Siemens Healthcare GmbH, SNVL Varay Laborix, STERYLAB Srl, Suretech Medical Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, Vector Medical, Inc., and Zamar Care.

Introducing ThinkMi Query: Revolutionizing Market Intelligence with AI-Driven Insights for the Breast Biopsy Device Market

We are proud to introduce ThinkMi Query, a cutting-edge AI product designed to change the way businesses interact with the breast biopsy device market. ThinkMi Query stands out as your leading market intelligence partner, delivering unparalleled insights through the power of AI. Whether it’s deciphering market trends or offering actionable intelligence, ThinkMi Query is designed to deliver precise, relevant answers to your most important business questions. This revolutionary tool is more than just a source of information; it’s a strategic asset that empowers decision-making with up-to-date data, giving you an edge in the highly competitive breast biopsy device market. Embrace the future of market intelligence with ThinkMi Query, where informed decisions lead to extraordinary growth.

Ask a question ThinkMi Query @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=query

Main topics:

1. Introduction
2. Research methodology
3. Summary
4. Market overview
5. Market insight
6. Breast Biopsy Devices Market by Product
7. Breast Biopsy Device Market by Tests
8. Breast Biopsy Device Market by Guidelines
9. Breast Biopsy Devices Market by End Use
10. The Breast Biopsy Device Market in America
11. Asia Pacific Breast Biopsy Devices Market
12. Breast Biopsy Devices Market in Europe, Middle East and Africa
13. Competitive Landscape
14. Competitive portfolio

Read more @ https://www.360iresearch.com/library/intelligence/breast-biopsy-device?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales and Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India – 411014.
[email protected]
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting firm headquartered in India, with clients and target markets spread across the globe.

We are a dynamic, agile company that believes in setting ambitious, purposeful goals and achieving them with the support of our greatest asset – our employees.

Fast on our feet, we have our ear to the ground when it comes to market news and volatility. Our market intelligence is urgent, timely and tailored to your needs, arming you with all the insights that support strategic decision-making.

Our clientele includes approximately 80% of the Fortune Global 500 companies, as well as leading consulting, research, and academic institutions that rely on our expertise in compiling data on niche markets. Our meta-insights are intelligent, impactful, and limitless, translating into actionable data that supports your drive to increase profitability, expand into niche markets, and discover new revenue opportunities.

This version was published on openPR.